The Department of Radiation Medicine (www.ohsu.edu/radmedicine) at Oregon Health & Science University’s Knight Cancer Institute is seeking an outstanding and highly interactive radiation oncologist for a 08-1.0 FTE, Clinical Associate, Assistant, Associate, or Full Professor Faculty position. Rank will be commensurate with experience and applicants must have an MD or equivalent degree, Board certification (or Board eligibility) is required. The ideal candidate would demonstrate excellence in clinical care. Interest in health services research and outcomes research is desirable.
This position will primarily be in clinical practice in scenic Roseburg, Oregon. Roseburg is the heart of the Land of Umpqua, a destination known for award winning wineries, fishing, rafting, biking, hiking, waterfalls, horseback riding, camping and a unique and thriving exotic wildlife park.
This small scenic town in Southern Oregon is about 175 miles South of Portland, and lies along the South Umpqua River. Roseburg is a family–oriented community that boasts an eclectic mixture of restaurants on and near the river, coffee shops, microbreweries and locally owned boutiques. Learn more at https://www.go-oregon.com/Roseburg/.
Preference will be given to candidates with a strong clinical care experience. The primary responsibilities are to direct programmatic expansion of the newly minted Service Collaboration of the Roseburg community-owned Community Cancer Center & OHSU Radiation Medicine. This is a unique opportunity to expand the programmatic reach of this beautful, integrated Cancer Center with strong on site and remote support from your OHSU Radaition Oncology colleagues. The successful candidate can periodically rotate at the main Portland campus and have the opportunity to build educational and/or research interests in a highly collegial and supportive environment. OHSU Knight Cancer Institute’s Department of Radiation Medicine is one of the largest treating practices in the Pacific Northwest. Our treatment sites include Varian, Elekta and TomoTherapy technology and utilize a variety of treatment planning systems in caring for our patients. Additionally, we have an active intraoperative program that includes Mobetron and IntraBeam. Our centers are integrated with medical oncology and radiology services at all sites.
The OHSU Knight Cancer Institute is an international leader in cancer research and precision treatment. The OHSU is the only National Cancer Institute (NCI)-designated Cancer Center between Sacramento and Seattle. Additionally the Knight Cancer Institute is the headquarters for the NCI’s SWOG collaborative, a cancer research cooperative group that designs and conducts multidisciplinary clinical trials to improve the practice of medicine in preventing, detecting and treating cancer and enhancing quality of life for cancer survivors.
To be considered for this exciting opportunity with the Knight Cancer Institute and the OHSU Department of Radiation Medicine, interested candidates should forward the following: (1) a cover letter outlining relevance of clinical care activities, (2) a current curriculum vita, and (3) the names and contact information of three references to:
Jerry J. Jaboin, MD, PhD - Executive Vice Chair
OHSU Department of Radiation Medicine
OHSU is an Equal Opportunity, Affirmative Action Employer of all protected classes, including veterans and individuals with disabilities. Women and minorities are encouraged to apply. Hiring is contingent upon eligibility to work in the United States.
Internal Number: 004
About Oregon Health & Science University Department of Radiation Medicine
The Department of Radiation Medicine dedicates itself to the foundation of the four pillars; Patient Care, Service, Research, and Education.
We take pride in teaching and educating our patients on the various cancer radiation treatments available and what they can expect during each treatment. As a teaching institution, our staff maintains a high level of professional standards furthering their education by attending seminars and collaborating closely with other teaching institutions.
These standards give our patients an advantage in fighting cancer and overcoming tumors by strategically and cost-effectively utilizing the latest technologies.
BACK TO TOP